The FDA-approved weight loss medication Wegovy is indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition
The subcutaneous tissue in the upper arm is thinner than the abdomen or thigh for most individuals, so a 45-degree angle with a shorter needle often works better here
If you miss your scheduled day, take the injection as soon as you remember, provided it is within 5 days (120 hours) of the missed timeline
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
Results Prevalence and patterns of abnormal acyl-carnitines Seventy-four (35%) of the 213 patients tested demonstrated an increase in three or more acyl-carnitines when initially measured
doi: 10.1002/j.1460-2075.1995.tb07042.x 108 NewbernePMBroitmanSSchragerTF
